- Home
- FRAF vs ANVS Comparison
FRAF vs ANVS Comparison
Compare FRAF & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRAF
- ANVS
- Stock Information
- Founded
- FRAF 1906
- ANVS 2008
- Country
- FRAF United States
- ANVS United States
- Employees
- FRAF N/A
- ANVS N/A
- Industry
- FRAF Major Banks
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- FRAF Finance
- ANVS Health Care
- Exchange
- FRAF Nasdaq
- ANVS Nasdaq
- Market Cap
- FRAF 127.4M
- ANVS 110.4M
- IPO Year
- FRAF N/A
- ANVS 2020
- Fundamental
- Price
- FRAF $30.60
- ANVS $7.96
- Analyst Decision
- FRAF
- ANVS Strong Buy
- Analyst Count
- FRAF 0
- ANVS 5
- Target Price
- FRAF N/A
- ANVS $30.60
- AVG Volume (30 Days)
- FRAF 4.7K
- ANVS 210.5K
- Earning Date
- FRAF 10-22-2024
- ANVS 11-06-2024
- Dividend Yield
- FRAF 4.20%
- ANVS N/A
- EPS Growth
- FRAF N/A
- ANVS N/A
- EPS
- FRAF 3.11
- ANVS N/A
- Revenue
- FRAF $69,344,000.00
- ANVS N/A
- Revenue This Year
- FRAF N/A
- ANVS N/A
- Revenue Next Year
- FRAF N/A
- ANVS N/A
- P/E Ratio
- FRAF $9.80
- ANVS N/A
- Revenue Growth
- FRAF 3.47
- ANVS N/A
- 52 Week Low
- FRAF $25.11
- ANVS $4.53
- 52 Week High
- FRAF $35.00
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- FRAF 48.46
- ANVS 46.55
- Support Level
- FRAF $29.85
- ANVS $7.84
- Resistance Level
- FRAF $31.38
- ANVS $8.48
- Average True Range (ATR)
- FRAF 0.44
- ANVS 0.52
- MACD
- FRAF 0.01
- ANVS -0.02
- Stochastic Oscillator
- FRAF 60.20
- ANVS 56.44
About FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.